Perrigo's shareholders reject Mylan takeover bid

Shares of over-the-counter drugmaker Perrigo sank early Friday after its stock owners rejected a hostile, $26 billion takeover bid from Mylan.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.